TAYLOR THORPE: Open Payments
NPI 1851993455 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,613 in 78 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,096 · 2025 $1,613
Food & beverage: $1,390Education: $223
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 14 | $475 |
| E.R. Squibb & Sons, L.L.C. | 24 | $322 |
| Otsuka America Pharmaceutical, Inc. | 10 | $218 |
| Alkermes, Inc. | 6 | $206 |
| Neurocrine BioSciences, Inc. | 10 | $148 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| ABBVIE INC. | 4 | $60 |
| Luye Pharma (USA) Ltd. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $17 |
Products named: COBENFY, AUSTEDO XR, INGREZZA, LYBALVI, UZEDY, ABILIFY ASIMTUFII, REXULTI, ARISTADA.
Industry payments across OH — which companies pay providers there.
